Previous close | 20.85 |
Open | 20.85 |
Bid | 26.90 |
Ask | 34.30 |
Strike | 220.00 |
Expiry date | 2024-12-20 |
Day's range | 20.85 - 20.85 |
Contract range | N/A |
Volume | |
Open interest | 12 |
ACTON, Mass., November 28, 2023--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at two upcoming investor conferences (all Eastern Time):
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
In this article, we shall discuss the 12 best diabetes stocks to buy now. To skip our detailed analysis of the global diabetes drugs industry in 2023, go directly and see 5 Best Diabetes Stocks to Buy Now. Diabetes is a chronic metabolic disease which is normally characterized by high blood glucose levels, which tend […]